SAFETY DATA SHEET. Section 1: IDENTIFICATION. ALFAXAN (alfaxalone 10 mg/ml) (10 ml), (10 ml samples, not for sale)

Transcription

1 Page 1 of 6 ISSUED: 18 June 2014 SAFETY DATA SHEET Section 1: IDENTIFICATION Product Name: Common name / synonyms: Product Code: Importer: Address: ALFAXAN (alfaxalone 10 mg/ml) ALFAXAN, Alfaxan Anesthetic Injection (10 ml), (10 ml samples, not for sale) Jurox Inc. American Century Tower II, 4520 Main Street, Kansas City, MO 64111, USA Emergency Telephone Number: ALFAXAN or Customer Centre: ALFAXAN or Recommended Use: Restrictions on use: Poison Help Line: An intravenous injectable anesthetic for use in cats and dogs. For veterinary use only. Federal law restricts this drug to use by or on the order of a licensed veterinarian (AAPCC 24 hour hotline) Section 2: HAZARDS IDENTIFICATION GHS hazard classification(s): Signal word: GHS hazard statement(s): GHS pictograms: GHS precautionary statement(s): Description of any hazards not otherwise classified identified during the classification process: Ingredient(s) with unknown toxicity; Not hazardous Controlled drug (CIV) Possible sedation or anaesthesia on self-injection. Section 3: COMPOSITION / INFORMATION on INGREDIENTS COMMON NAME & CAS No. (and / or other CONTENT CHEMICAL NAME* SYNONYMS unique identifiers) (% by weight) Alfaxalone % 2-Hydroxypropyl-beta-cyclodextrin Hydroxypropylbetadex % Sodium chloride < 1 % Sodium phosphate dibasic Sodium phosphate < 1 % Potassium phosphate monobasic Potassium phosphate <1 % Hydrochloric acid (added to adjust ph) Water Water for Injection to 100 % There are no impurities or stabilizing additives which are themselves classified and which contribute to the classification of the substance. < 1 %

2 Page 2 of 6 Section 4: FIRST AID MEASURES First Aid Measures: Inhalation: Ingestion: Skin: Eye: Injected: Advice to Doctor: Important symptoms: Consult the Poisons Help Line on or a doctor immediately in every case of suspected chemical poisoning. Never give fluids or induce vomiting if a patient is unconscious or convulsing regardless of cause of injury. If medical advice/attention is needed, have product container or label at hand. Remove patient to fresh air. Lay patient down and keep warm and rested. If breathing is shallow or has stopped, ensure airway is clear and apply resuscitation. If breathing is difficult, give oxygen. Seek medical assistance immediately. If swallowed, DO NOT induce vomiting. Rinse mouth. Keep subject warm and at rest. For advice, contact the Poisons Help Line on Seek medical assistance immediately. If skin contact occurs, wash affected area thoroughly with plenty of soap and water for at least 20 minutes. If skin irritation or rash occurs, get medical advice/attention. Remove and wash / dispose of contaminated clothing promptly. If eye contact occurs, rinse cautiously with water for at least 20 minutes. Continue rinsing. If eye irritation persists, get medical advice/attention. Treat as for needle-stick injury. Wash area well and disinfect. If other symptoms become evident, seek medical advice. Alfaxalone is a steroid anesthetic. Treat symptomatically. Sedation or anesthesia. Possible apnea. Section 5: FIRE FIGHTING MEASURES Extinguishing Media: There is no restriction on the type of extinguisher which may be used. Use extinguishing media suitable for surrounding area. Hazardous Combustion If involved in a fire, may emit noxious fumes. Non-combustible not considered to be a Products: significant fire risk. Flash Point: Protective Equipment: Not flammable (aqueous product). For individual 10 ml bottles: no fire risk anticipated. For the bulk product: Gas-tight chemical resistant suit, protective gloves and breathing apparatus Section 6: ACCIDENTAL RELEASE MEASURES Spills and Disposal: Wear appropriate protective clothing. Exclude non-essential people from the area. Contain spill and sweep up / absorb with inert material such as soil, sand or absorbent granules and place in a sealable waste container. Ventilate area and wash spill site after pick-up complete. Dispose of waste safely according to the applicable federal, state or local regulations. Protective Clothing: For appropriate personal protective equipment see section 8. Environmental Precautions: Prevent from entering drains, waterways or sewers. If spill does enter waterways contact local authority. Section 7: HANDLING AND STORAGE Handling: This is a Controlled Drug (Schedule IV) with federal law restricting this drug to use by or on the order of a licensed veterinarian. Prescribing practitioners must adhere to the laws and regulations of the FDA, DEA, the States in which they are practising and their licencing boards. In the event that discrepancies between Federal and State laws exist the more stringent of the two must be followed. Do not eat, drink, smoke or apply cosmetics while handling the product. Wash hands thoroughly after handling. Avoid accidental injection, ingestion, inhalation and contact with skin and eyes. Use personal protective equipment as required

3 Page 3 of 6 Storage: Keep out of reach of children. Store individual vials of product at controlled room temperature 20 to 25 C (68 to 77 F) with excursions between 15 and 30 C (59 to 86 F), under secure conditions appropriate to local requirements for this class of drug. Protect from freezing. No known incompatibilities for storage. Other Information: Always read the label before use. See label for further information on handling and storage. Section 8: EXPOSURE CONTROLS/PERSONAL PROTECTION Exposure Limits: No exposure limits have been assigned for the manufactured product. Use with adequate ventilation. Follow standard veterinary product handling procedures. Do not handle until all safety precautions have been read and understood. Due to the small volumes involved, and the methods of administration, exposure under normal conditions of use would likely be limited to splashing on to skin or in to eyes, or accidental self-injection. Exposure limits for the major components are as follows:- Component Exposure limits Type mg/m3 ppm µg/m3 Note Alfaxalone OSHA-PEL NE NE NE - Alfaxalone ACGIH-TLV NE NE NE - 2-Hydroxypropyl-beta-cyclodextrin OSHA-PEL NE NE NE - 2-Hydroxypropyl-beta-cyclodextrin ACGIH-TLV NE NE NE - Water OSHA-PEL NE NE NE - Water ACGIH-TLV NE NE NE - NE = Not established Engineering Controls: Protective Equipment: Hygiene Precautions: Additional controls not normally required Protective gloves and eyewear As for good veterinary practice. Section 9: PHYSICAL AND CHEMICAL PROPERTIES Appearance Clear colorless solution Upper / lower Not applicable flammability or explosive limits Odor Odorless Vapor pressure Not available Odor threshold Not applicable Relative vapor density Not available (air = 1) ph Relative density / S.G. = specific gravity Melting point / freezing point Not available Solubility(ies) Water: Miscible Initial boiling point and Not available Partition co-efficient: Not available boiling range n-octanol / water Flash point Not applicable Auto-ignition Not applicable temperature Evaporation rate Not available Decomposition Not available temperature Flammability (solid, gas) Not applicable Viscosity Not available

4 Page 4 of 6 Section 10: STABILITY AND REACTIVITY Reactivity: Chemical stability: Hazardous polymerization will not occur. Stable under normal conditions of storage and handling. When stored appropriately this product should show no significant degradation before the expiry date indicated on the packaging. Possibility of hazardous Not known to occur. reactions: Conditions to avoid (e.g. static discharge, shock or vibration): Incompatible material: Hazardous decomposition products: Avoid freezing. This product is generally compatible with other common materials in a veterinary facility. known. Section 11: TOXICOLOGICAL INFORMATION Inhalation: Ingestion: Skin: Eye: Injection: Chronic Effects: Reproductive Toxicity: Mutagenicity: Carcinogenicity: Unlikely to present an inhalation hazard under normal conditions of use, due to the non-volatile nature of the product. Alfaxalone: Oral LD 50; > 300 mg/kg (rat) Hydroxypropyl beta cyclodextrin: Oral LD 50; >5,000 mg/kg (rat) Unlikely to present a hazard, due to the low oral bioavailability of alfaxalone. Not a skin irritant. Not a skin sensitiser. Alfaxalone: Skin LD 50; 2,200 mg/kg (rat) Not classified as an eye irritant, but may cause transient discomfort and redness following eye contact. Effects may vary in severity according to the quantity involved, from localised site reaction (pain, redness, swelling) to a more acute systemic reaction. Significant CNS effects are expected only from the intravenous route, and this is unlikely from accidental self-injection. Alfaxalone: Intravenous LD 50: 19 mg/kg (rat) No adverse effects were reported from intraperitoneal administration of alfaxalone to rats of up to 50 mg/kg/day for one month, or up to 20 mg/kg/day for 3 months. Not known to affect reproduction. Studies using alfaxalone in pregnant mice, rats and rabbits have demonstrated no deleterious effects on gestation of the treated animals or on the reproductive performance of their offspring. Alfaxalone is not considered to be mutagenic. There are no reports of the carcinogenicity of Alfaxan in animals in published literature or pharmacovigilance data, and no pre-neoplastic lesions were observed in repeat dose toxicity or target species safety studies. Alfaxalone is classified in Group 3 (Not classifiable as to its carcinogenicity to humans) in the IARC Monographs. Alfaxalone has not been reviewed in NTP Reports on Carcinogens. Section 12: ECOLOGICAL INFORMATION Aquatic toxicity: Persistence / Biodegradability: Bioaccumulation: Mobility in soil:

5 Page 5 of 6 Section 13: DISPOSAL INFORMATION Product Disposal: Container Disposal: All waste materials must be properly characterized. Further, disposal should be performed in accordance with federal, state and local regulatory requirements. Dispose of container and unused contents in accordance with federal, state and local regulations. This material is not hazardous as defined by 49 CFR by the U.S. Department of Transportation. ADR/ADG/DOT STATUS: Not regulated Section 14: TRANSPORT INFORMATION IMDG STATUS: ICAO/IATA STATUS: UN number: UN proper shipping name: Transport hazard class(es): Packing group: Not regulated. Not regulated. Not classed as a Dangerous Good for transport purposes by road, sea or air. Not classed as a Dangerous Good for transport purposes by road, sea or air. DOT Label(s) Required: North American Emergency Response Guidebook Number (1996): Environmental Hazards: Transport in bulk: Transport Canada Transportation of Dangerous Goods Regulations: Special precautions: Not a Marine Pollutant. Not regulated according to Annex II of MARPOL 73/78 and the IBC code. Not regulated. FDA Approval: NADA Harmonised Tariff Code: TSCA Inventory Status: Exempt Section 15: REGULATORY INFORMATION CERCLA Status: RCRA Status: Proposition 65 Status: Not determined Not an RCRA Hazardous Waste Does not contain chemicals known to the state of California to cause cancer or reproductive harm. USA Regulations: Substance SARA 302 SARA 304 SARA 313 PROP 65 Status Status Status Alfaxalone Not listed Not listed Not listed Not listed

6 Page 6 of 6 Canadian Regulations: Canadian Inventory: Not determined. Canadian NDSL: Not determined. WHMIS Hazard Class: Not determined. Section 16: OTHER INFORMATION This information is based on data believed by Jurox Pty Limited to be accurate at the time of writing but is subject to change without notice. It is given in good faith, but no warranty expressed or implied is made as to its accuracy, completeness otherwise and no assumption of liability from howsoever arising is made by Jurox Pty Limited by reason of the provision of this information. Every person dealing with the materials referred to herein does so at his/her own risk absolutely and must make independent determinations of suitability and completeness of information from all sources to ensure their proper use. This is the first SDS prepared for this product. The format follows that prescribed in the Hazard Communication Standard (HCS) (29 CFR (g)) revised in Legend AAPCC American Association of Poison Control Centers ACGIH American Conference of Governmental Industrial Hygienists ADG Australian Dangerous Goods Code ADR European Agreement concerning the International Carriage of Dangerous Goods by Road CAS Chemical Abstracts Service Number CERCLA US EPA law, Comprehensive Environmental Response, Compensation and Liability Act DOT US Department of Transport regulations EPA US Environmental Protection Agency FDA Food and Drug Administration, US Dept. of Health and Human Services HCS Hazard Communication Standard IARC International Agency for Research on Cancer IATA International Air Transport Association IBC Code International Bulk chemical Code ICAO International Civil Aviation Organization IMDG International Maritime Dangerous Goods Code LD50 Dosage providing 50% mortality MARPOL 73/78 International Convention for the Prevention of Pollution from Ships, 1973 as modified by the Protocol of 1978 NADA New Animal Drug Application NDSL Non-Domestic Substances List NTP National Toxicology Program OSHA Occupational Safety & Health Administration (United States Department of Labor) PEL Permissible Exposure Limit RCRA US EPA, Resource Conservation and Recovery Act SARA Superfund Amendments and Reauthorization Act Prop 65 California Proposition 65 SDS Safety Data Sheet TSCA Toxic Substance Control Act TLV Threshold Limit Value UN United Nations VMD United Kingdom Veterinary Medicines Directorate VSD Veterinary Substances Database WHMIS Canadian Workplace Hazardous Materials Information System References VMD Assessment Report for Alfaxan 10 mg/ml Solution for Injection for Dogs and Cats VSDB entry on Alphaxalone (